MIM-727 Investigational Site — Nashville, Tennessee

MIM-727 Investigational Site is a clinical research site located in Nashville, Tennessee, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

MIM-727 Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Keratoconjunctivitis Sicca.

Sponsors: Mimetogen Pharmaceuticals USA, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MIM-727 Investigational Site?

MIM-727 Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MIM-727 Investigational Site conducted?

MIM-727 Investigational Site has 1 clinical trials on record. Their work covers Keratoconjunctivitis Sicca.

Is MIM-727 Investigational Site accredited by Crixeo Clinical Trials?

MIM-727 Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MIM-727 Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.